As many as a third of people with “wet” age-related macular degeneration, a blinding retinal disease, may someday be able to safely stop eye injection therapy without further vision loss, a preliminary study shows. The findings fall short of setting a timeline for ending treatment or predicting precisely which patients can stop injections, the researchers say, but add to growing evidence that many people with the disease may not need the lifelong monthly medication currently recommended. The findings, the researchers say, also point to specific proteins produced at different levels in the eyes of those who stopped therapy, which may lead to the development of a test to accurately identify who may be weaned off medication. “Such a test could let us tell patients early on how well they would do and when they might be able to stop,” says Akrit Sodhi, professor of ophthalmology and associate professor of ophthalmology …